The US Department of Health and Human Services has introduced a new initiative aimed at reforming clinical trials, with some outlets suggesting this is a move to counter China's influence in the field. The initiative is described as a department-wide effort to restore American leadership in clinical trials, with goals including speeding up certain trials. Details of the plan vary, but it appears to involve proposals to accelerate the clinical trial process, though the scope and specifics of the reforms are not entirely clear.